INTECH Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

INTECH Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.7K	Sell	12,704 -36	-0.3%	-$235	﹤0.01%	1985
2026 Q1	$88K	Sell	12,740 -10,512	-45%	-$81.1K	﹤0.01%	1915
2025 Q4	$205K	Sell	23,252 -2,586	-10%	-$14.2K	﹤0.01%	1976
2025 Q3	$129K	Buy	25,838 +75	+0.3%	+$347	﹤0.01%	2197
2025 Q2	$122K	Sell	25,763 -11,368	-31%	-$49.7K	﹤0.01%	2241
2025 Q1	$170K	Buy	37,131 +8,591	+30%	+$40K	﹤0.01%	2154
2024 Q4	$137K	Buy	28,540 +10,526	+58%	+$50.5K	﹤0.01%	2140
2024 Q3	$84.5K	Buy	+18,014	New	+$96.6K	﹤0.01%	1917

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's VNDA Position: Q2 2026 in Review

INTECH Investment Management reduced its Vanda Pharmaceuticals (VNDA) stake by 0.28% in Q2 2026, selling an estimated $235 and leaving 12,704 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

INTECH Investment Management first reported a position in VNDA in Q3 2024 and has held it in 8 quarters since. The position peaked at $205K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

INTECH Investment Management held 12,704 shares of Vanda Pharmaceuticals worth $77.7K as of Q2 2026.
INTECH Investment Management sold 36 Vanda Pharmaceuticals shares in Q2 2026, an estimated $235.
Vanda Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1985 holding.
INTECH Investment Management first reported a position in Vanda Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Vanda Pharmaceuticals position peaked at $205K in Q4 2025.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.